Cite
Enhancing fetal outcomes in GCK-MODY pregnancies: a precision medicine approach via non-invasive prenatal GCK mutation detection.
MLA
Schwitzgebel, Valérie M., et al. “Enhancing Fetal Outcomes in GCK-MODY Pregnancies: A Precision Medicine Approach via Non-Invasive Prenatal GCK Mutation Detection.” Frontiers in Medicine, May 2024, pp. 1–8. EBSCOhost, https://doi.org/10.3389/fmed.2024.1347290.
APA
Schwitzgebel, V. M., Blouin, J.-L., Dehos, B., Köhler-Ballan, B., Puder, J. J., Rieubland, C., Triantafyllidou, M., Zanchi, A., Abramowicz, M., & Nouspikel, T. (2024). Enhancing fetal outcomes in GCK-MODY pregnancies: a precision medicine approach via non-invasive prenatal GCK mutation detection. Frontiers in Medicine, 1–8. https://doi.org/10.3389/fmed.2024.1347290
Chicago
Schwitzgebel, Valérie M., Jean-Louis Blouin, Barbara Dehos, Bettina Köhler-Ballan, Jardena J. Puder, Claudine Rieubland, Maria Triantafyllidou, Anne Zanchi, Marc Abramowicz, and Thierry Nouspikel. 2024. “Enhancing Fetal Outcomes in GCK-MODY Pregnancies: A Precision Medicine Approach via Non-Invasive Prenatal GCK Mutation Detection.” Frontiers in Medicine, May, 1–8. doi:10.3389/fmed.2024.1347290.